Verndari, Inc., an early-stage biotechnology company, is transforming vaccines through next-generation vaccine science and technology. Verndari aims to improve global health by enabling more effective delivery of vaccines, at a lower cost, to populations around the world. Verndari has a pipeline of several innovative platforms that simplify vaccine delivery and enhance vaccine performance. Verndari’s VaxiPatch™, an intradermal microarray vaccine delivery system, is easy-to-use, painless, highly effective, dose-sparing, and has the potential to be self-administered. Verndari’s proprietary science reduces vaccine cold chain distribution requirements and optimizes vaccine manufacturing, helping to overcome the technical hurdles that have impeded universal access to life-saving vaccines.